RFXANK
DNA-binding protein RFXANK
Also known as: ANKRA1, BLS, F14150_1, MGC138628, RFX-B, RFXK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14593
- Gene
- RFXANK
- Ensembl
- ENSG00000064490
- Chromosome
- 19
- Canonical length
- 260 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Major histocompatibility (MHC) class II molecules are transmembrane proteins that have a central role in development and control of the immune system. The protein encoded by this gene, along with regulatory factor X-associated protein and regulatory factor-5, forms a complex that binds to the X box motif of certain MHC class II gene promoters and activates their transcription. Once bound to the promoter, this complex associates with the non-DNA-binding factor MHC class II transactivator, which controls the cell type specificity and inducibility of MHC class II gene expression. This protein contains ankyrin repeats involved in protein-protein interactions. Mutations in this gene have been linked to bare lymphocyte syndrome type II, complementation group B. Multiple alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
260 residues, UniProt reviewed canonical sequence.
>O14593|RFXANK
1 MELTQPAEDL IQTQQTPASE LGDPEDPGEE AADGSDTVVL SLFPCTPEPV NPEPDASVSS
61 PQAGSSLKHS TTLTNRQRGN EVSALPATLD SLSIHQLAAQ GELDQLKEHL RKGDNLVNKP
121 DERGFTPLIW ASAFGEIETV RFLLEWGADP HILAKERESA LSLASTGGYT DIVGLLLERD
181 VDINIYDWNG GTPLLYAVRG NHVKCVEALL ARGADLTTEA DSGYTPMDLA VALGYRKVQQ
241 VIENHILKLF QSNLVPADPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFXANK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 39 nTPM
- esophagus: 38 nTPM
- kidney: 38 nTPM
- spleen: 37 nTPM
- thyroid gland: 36 nTPM
- basal ganglia: 33 nTPM
Single-cell type
- esophageal apical cells: 113 nCPM
- megakaryocytes: 99 nCPM
- hofbauer cells: 86 nCPM
- esophageal suprabasal cells: 85 nCPM
- extravillous trophoblasts: 77 nCPM
- cytotrophoblasts: 75 nCPM
Immune cell
- plasmacytoid DC: 54 nTPM
- eosinophil: 52 nTPM
- basophil: 49 nTPM
- memory B-cell: 42 nTPM
- naive B-cell: 42 nTPM
- T-reg: 41 nTPM
Brain region
- medulla oblongata: 29 nTPM
- basal ganglia: 27 nTPM
- white matter: 27 nTPM
- cerebellum: 26 nTPM
- hypothalamus: 25 nTPM
- pons: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RFXANK.
Disease | AllUniProt
Conditions RFXANK is implicated in, by any mechanism.
- MHC class II deficiency 2 (MHC2D2) MIM:620815
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 332 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- MHC class II deficiency
- MHC class II deficiency 2
- MHC class II deficiency 1
- RFXANK-related disorder
- MHC class II deficiency 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of MHC class II biosynthetic process
- positive regulation of transcription by RNA polymerase II
- Ras protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RFXANK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFXANK as an antibody target. Whether an autoantibody or antibody against RFXANK could matter depends on whether native RFXANK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFXANK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RFXANK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...